AssayIndex
Reports by quarter

Reports submitted in 2026-Q3 · page 2

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.93 % area, n=455. Read the 2026-Q3 state-of-the-index report →

455 records12 pagesmedian on this page 98.94 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041766BPC-157TFSTFS-{CAT}-1156Janoshik2026-Q399.546.34—Buyer-sourced1MARGINAL
AX-2026-043345LeuprolideWXTWXT-2604-K2596Janoshik2026-Q398.935.28—Buyer-sourced0PASS
AX-2026-043295LiraglutideCPCCPC-2602-G9942Janoshik2026-Q397.345.17106.3Buyer-sourced0FAIL
AX-2026-043094RetatrutideKPKP-2607-H5774PeptideMeter2026-Q396.326.40—Buyer-sourced0FAIL
AX-2026-041638SemaglutideFGPFGP-2602-M8547Janoshik2026-Q399.402.75105.8Buyer-sourced0PASS
AX-2026-043424L-Glutathione (reduced)WXTWXT-2605-B3833PeptideMeter2026-Q398.376.86—Buyer-sourced0FAIL
AX-2026-043288TirzepatideCPCCPC-2607-L1516Janoshik2026-Q396.895.11101.1Laboratory-retained0FAIL
AX-2026-042637SemaglutideSWBSWB-2602-X7905Janoshik2026-Q398.374.26102.9Buyer-sourced0PASS
AX-2026-042491SS-31 (Elamipretide)HomopeptideHOMO-2604-D5484Kestrel2026-Q399.933.24—Supplier-supplied0PASS
AX-2026-042473LL-37HomopeptideHOMO-2602-G5165Janoshik2026-Q399.015.00—Buyer-sourced0PASS
AX-2026-042441RetatrutideHomopeptideHOMO-2605-V4718Medutest2026-Q398.934.22—Buyer-sourced0PASS
AX-2026-041682CJC-1295 with DACTFSTFS-{CAT}-9675Nordanalyt2026-Q398.943.24—Buyer-sourced0PASS
AX-2026-042090MOTS-cHYBHYB-2606-D7858Janoshik2026-Q399.572.36—Buyer-sourced1FAIL
AX-2026-041641SemaglutideFGPFGP-2602-M8547PeptideMeter2026-Q398.982.38105.0Buyer-sourced0PASS
AX-2026-041427RetatrutideQYBQYB-2604-B4920PeptideMeter2026-Q397.932.45101.7Buyer-sourced0PASS
AX-2026-043374SemaglutideWXTWXT-2604-C3248Janoshik2026-Q397.003.56—Buyer-sourced1MARGINAL
AX-2026-041913IpamorelinSinoPepSNP-2606-L4478PeptideMeter2026-Q398.885.28—Buyer-sourced0FAIL
AX-2026-041786RetatrutideASYASY-{CAT}-2288VendorInvestigate2026-Q398.786.59—Buyer-sourced0PASS
AX-2026-043377SemaglutideWXTWXT-2604-C3248PeptideMeter2026-Q397.204.08—Buyer-sourced1MARGINAL
AX-2026-042598SemaglutideHJHJ-2608-C7002Janoshik2026-Q399.593.84—Buyer-sourced0PASS
AX-2026-042339SermorelinTFCTFC-2605-Y2176Kestrel2026-Q399.934.14—Supplier-supplied1FAIL
AX-2026-041836SurvodutideGSPGSP-2603-E3156Janoshik2026-Q398.655.3490.3Buyer-sourced0PASS
AX-2026-041782TB-500ASYASY-{CAT}-2167Nordanalyt2026-Q399.933.94—Buyer-sourced0PASS
AX-2026-041914IpamorelinSinoPepSNP-2606-L4478Janoshik2026-Q399.145.49—Buyer-sourced0PASS
AX-2026-041610TirzepatideFGPFGP-2603-L7753Janoshik2026-Q398.812.45101.0Buyer-sourced0PASS
AX-2026-041335SemaglutideWWBWWB-2606-N3192Janoshik2026-Q399.154.2798.9Buyer-sourced0PASS
AX-2026-041271LiraglutideWWBWWB-2607-X2189Medutest2026-Q399.524.5797.4Buyer-sourced1MARGINAL
AX-2026-043445BPC-157BCHBCH-2603-G4350Nordanalyt2026-Q398.424.8793.6Buyer-sourced1MARGINAL
AX-2026-042474LL-37HomopeptideHOMO-2602-G5165Janoshik2026-Q399.185.44—Buyer-sourced0PASS
AX-2026-041909IpamorelinSinoPepSNP-2606-L4478PeptideMeter2026-Q399.005.4889.5Buyer-sourced1MARGINAL
AX-2026-041683CJC-1295 with DACTFSTFS-{CAT}-9675Medutest2026-Q398.683.4697.0Buyer-sourced0PASS
AX-2026-043440BPC-157BCHBCH-2603-G4350VendorInvestigate2026-Q398.614.11—Buyer-sourced1MARGINAL
AX-2026-043327N-Acetyl Semax AmideCPCCPC-2602-D1905Nordanalyt2026-Q399.055.6790.6Buyer-sourced1FAIL
AX-2026-042784CJC-1295 (no DAC)GGPepsGGPE-2606-E1234Medutest2026-Q398.274.55—Buyer-sourced0PASS
AX-2026-042519SemaxHomopeptideHOMO-2605-S5227Medutest2026-Q399.755.55—Buyer-sourced0PASS
AX-2026-042509IGF-1 LR3HomopeptideHOMO-2607-P5131Medutest2026-Q398.636.23103.0Buyer-sourced0PASS
AX-2026-042214SemaglutideTFCTFC-2604-X9037Kestrel2026-Q399.874.66103.1Laboratory-retained0PASS
AX-2026-041895IpamorelinSinoPepSNP-2602-B3833Janoshik2026-Q399.934.72105.9Buyer-sourced1MARGINAL
AX-2026-041637SemaglutideFGPFGP-2602-M8547PeptideMeter2026-Q399.402.83—Laboratory-retained0PASS
AX-2026-041428RetatrutideQYBQYB-2604-B4920Janoshik2026-Q398.353.20—Laboratory-retained0PASS